Clean Science & Technology
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Clean Science & Technology is navigating a complex macroeconomic landscape characterized by raw material volatility and competitive pressures. Management's recent commentary highlights a strategic pivot towards high-value specialty chemicals, particularly in the HALS segment, which is expected to drive revenue growth with a targeted CAGR of 18% over FY26-28. The upcoming commercialization of the Performance Chemical 2 plant is anticipated to enhance capacity and operational efficiency, supporting Vista's forecast of improving margins and stable revenue recovery. However, challenges remain, including elevated raw material costs and competition from established players like BASF. The specialty chemicals industry is experiencing structural growth, bolstered by strong domestic demand and favorable trade agreements, which aligns with Vista's positive long-term outlook. Over the next 12-24 months, key opportunities include expanding the HALS portfolio and leveraging international partnerships, while watchpoints include managing input cost volatility and maintaining competitive pricing. Overall, Clean Science & Technology's focus on innovation and sustainable practices positions it well for future growth, despite the inherent risks in the current environment
Why We Like This Stock
- Strategic partnerships and long-term supply agreements are expected to drive capacity expansions and revenue growth
- The upcoming commercialization of the Performance Chemical 2 plant is anticipated to enhance operational efficiency and margins
- The HALS segment is emerging as a strong growth driver, with exports increasing significantly
Things To Watch Out For
- Elevated raw material prices and logistics disruptions pose risks to profitability
- Intense competition in the HALS segment from major players like BASF could pressure market share
- The overall cautious macroeconomic environment may impact demand and pricing strategies
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 791 | 967 | 957 | 1,018 | 1,116 |
| Profit Before Tax (Cr.) | 323 | 357 | 310 | 327 | 370 |
| PBT Margin | 40.8% | 36.9% | 3239.3% | 32.2% | 33.2% |
| Net Profit (Cr.) | 248 | 260 | 222 | 233 | 264 |
| Earnings Per Share | 23.3 | 24.4 | 20.8 | 22.0 | 24.8 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| IDBI Capital | ► Hold | 857 | 15-May-2026 |
| Motilal Oswal | ► Neutral | 790 | 03-Aug-2026 |
| Prabhudas Liladhar | ► Hold | 745 | 03-Aug-2026 |
Company Overview
Show Company Profile
Clean Science and Technology Limited, together with its subsidiaries, manufactures fine and specialty chemicals in India, China, the Americas, Europe, and internationally. It operates through Performance Chemicals, FMCG Chemicals, and Pharmaceutical & Agro Intermediates segments. The company offers performance chemicals, including monomethyl ether of hydroquinone, butylated hydroxy anisole, tertiary butyl hydroquinone, hindered amine light stabilisers, and butylated hydroxytoluene, as well as clean antiOX 962, 4-oxo tempo, 4-butoxy tempo, clean light stab 770, 4-hydroxy tempo, l-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, and dimethyl sebacate. It also provides FMCG chemicals, such as 4-methoxy acetophenone, anisole, guaiacol, butylated hydroxy anisole, l-ascorbyl palmitate, tertiary butyl hydroquinone, para di-methoxy benzene, and ortho methoxy toluene. In addition, the company offers pharmaceutical and agro intermediates, which include guaiacol, dicyclohexyl carbodiimide, veratrole, DHDT, para benzoquinone, para di-methoxy benzene, anisole, and ortho methoxy toluene. It exports its products and serves polymers, coatings, food, automotive, construction, cosmetics, personal care, fragrances, pharmaceuticals, agrochemical manufacturers, specialty chemical firms, and other industries. The company was incorporated in 2003 and is headquartered in Pune, India.